Parkside Investments’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.62M Sell
103,991
-16,566
-14% -$1.37M 1.17% 27
2025
Q1
$9.78M Sell
120,557
-2,950
-2% -$239K 1.44% 22
2024
Q4
$11.1M Buy
123,507
+2,050
+2% +$185K 1.67% 18
2024
Q3
$12M Buy
121,457
+3,040
+3% +$300K 1.81% 15
2024
Q2
$11M Buy
118,417
+24,665
+26% +$2.29M 1.73% 15
2024
Q1
$8.9M Buy
93,752
+9,395
+11% +$891K 1.41% 29
2023
Q4
$7.53M Sell
84,357
-2,000
-2% -$179K 1.27% 35
2023
Q3
$6.31M Sell
86,357
-163
-0.2% -$11.9K 1.16% 39
2023
Q2
$7.2M Sell
86,520
-3,075
-3% -$256K 1.34% 34
2023
Q1
$6.83M Buy
89,595
+1,600
+2% +$122K 1.29% 36
2022
Q4
$7.3M Buy
87,995
+1,200
+1% +$99.6K 1.46% 30
2022
Q3
$6.88M Buy
86,795
+4,340
+5% +$344K 1.48% 32
2022
Q2
$6.12M Buy
82,455
+545
+0.7% +$40.5K 1.29% 35
2022
Q1
$7.36M Buy
81,910
+28,575
+54% +$2.57M 1.44% 25
2021
Q4
$5.97M Buy
+53,335
New +$5.97M 1.15% 33
2021
Q1
Sell
-40,785
Closed -$5.74M 93
2020
Q4
$5.74M Sell
40,785
-6,725
-14% -$947K 1.27% 27
2020
Q3
$5.29M Sell
47,510
-7,395
-13% -$824K 1.39% 22
2020
Q2
$6.15M Sell
54,905
-12,290
-18% -$1.38M 1.63% 12
2020
Q1
$5.2M Sell
67,195
-2,390
-3% -$185K 1.72% 12
2019
Q4
$6.62M Buy
69,585
+5,700
+9% +$542K 1.61% 15
2019
Q3
$4.87M Buy
63,885
+1,675
+3% +$128K 1.3% 24
2019
Q2
$5.46M Buy
62,210
+47,195
+314% +$4.14M 1.42% 22
2019
Q1
$1.36M Buy
15,015
+4,015
+37% +$363K 0.37% 70
2018
Q4
$789K Buy
+11,000
New +$789K 0.34% 74